Anixa Biosciences, Inc. (ANIX) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ANIX is $5.83, representing a +102.4% upside from the current price of $2.88. Price targets range from a low of $3.50 to a high of $10.00.
